Asher Dewhurst, Vice President

Asher Dewhurst spent a decade in equity research primarily focused on the health care service sector. Asher began his Wall Street career with Raymond James & Associates in 1998, as an equity research liaison advising their extensive retail network of market trends and stock recommendations. 

In 2000, Asher moved on to research associate covering the health care service sector.  In this role, he covered the pharma service, health care IT, and skilled nursing sectors.  In addition to company-specific reports and comments, Asher authored industry reports that highlighted trends and created forecasts. 

In 2004, Asher joined Friedman Billings Ramsey to help build out their health care presence.  With a continued focus on pharma service, health care IT, and skilled nursing, Asher expanded his coverage to include patient-centric care companies and health care REITs.  During his time with FBR, his team received numerous recognitions, including StarMine #1 earnings estimator 2007 and 2006 and was Asher was quoted in leading publications, such as Baron’s, for his work on the HIT industry.

Asher was promoted to Vice President in late 2007 to broaden FBR’s pharma service coverage.  His team was early to recognize the FDA’s emphasis on drug safety and the impact on drug approvals.   

During his career on Wall Street, Asher participated in various capital raises and IPOs for companies such as: Phase Forward, Emageon, and specialty Medicare Advantage companies.  Asher was named the Pegasus Award winner for 2006 within FBR for his contributions to the firm.

Asher received his B.S. in Finance with honors and a minor in Economics from the Warrington College of Business from the University of Florida. He lives in Burke, VA, with his wife and two children.